Table 2.
Case | Age / sex | Survival | NF | APP | BACE | PS1 | AMY 117 | A-β (1-42) | α-syn | Tau |
---|---|---|---|---|---|---|---|---|---|---|
A | 56f | 4h | - | +++ | ++ | + | - | - | +++ | - |
B | 47m | 12h | - | - | - | - | - | - | - | - |
C | 51f | 12h | - | + | + | - | + | + | + | - |
D | 5m | 13h | - | + | + | - | - | - | + | - |
E | 57m | 15h | - | ++ | + | + | + | + | + | - |
F | 75m | 16h | - | ++ | + | + | - | - | + | - |
G | 28m | 18h | - | + | + | + | + | + | + | - |
H | 60f | 24h | - | + | + | + | + | + | + | - |
I | 65m | 27h | - | +++ | ++ | + | + | + | ++ | - |
J | 47m | 36h | - | + | - | + | + | + | + | + |
K | 16m | 7d | - | - | - | ++ | ++ | ++ | + | - |
L | 15f | 8d | - | +++ | +++ | +++ | +++ | +++ | +++ | - |
M | 79f | 8d | - | - | - | - | - | - | - | - |
N | 31m | 27d | + | + | - | - | + | + | - | - |
O | 18m | 4w | ++ | ++ | + | + | ++ | ++ | - | - |
P | 23m | 4w | ++ | ++ | ++ | ++ | ++ | ++ | - | - |
Q | 73f | 4w | - | +++ | +++ | ++ | +++ | +++ | +++ | ++ |
R | 76m | 5w | + | + | - | - | + | + | - | - |
S | 15m | Control | + | +++ | - | - | - | - | - | - |
T | 26m | Control | - | - | - | - | - | - | - | - |
U | 54m | Control | - | - | - | - | - | - | - | - |
V | 21f | Control | - | - | - | - | - | - | - | - |
W | 73f | Control | - | - | - | - | - | - | - | - |
X | 38f | Control | - | - | - | - | - | - | - | - |
Cases S-X are control subjects. (-): no occurrence of profiles in a microscopic field (~100μm2); (+): low occurrence of profiles in a microscopic field; (++): moderate occurrence of profiles in a microscopic field; (+++): frequent occurrence of profiles in a microscopic field. NF = neurofilament, APP = amyloid precursor protein, BACE = beta amyloid cleaving enzyme, PS1 = presenilin-1, AMY117 = amyloid 100kd protein, Aβ = amyloid beta, α-syn = alpha synuclein,.